LNTH Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Lantheus Holdings Inc. Stock Analysis LNTH
United States Health Care Mid Cap Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 808 full-time employees. The company went IPO on 2015-06-25. The company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, and others. Its pipeline includes B amyloid positron emission tomography (PET) imaging agent, NAV-4694, also known as F18-flutafuranol. The company has pre-clinical assets, specifically the TROP2 and DUNP19.
Read More LNTH Chart
Lantheus Holdings Inc vs S&P 500 Comparative Returns
Analysis of LNTH stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Lantheus Holdin... (LNT...) -10.08%
- S&P 500 -4.27%
Lantheus Holdin... Underperformed S&P 500 by 5.81%
1Y Performance
- Lantheus Holdin... (LNT...) 7.96%
- S&P 500 8.86%
Lantheus Holdin... Underperformed S&P 500 by 0.90%
3Y Performance
- Lantheus Holdin... (LNT...) 44.83%
- S&P 500 37.21%
Lantheus Holdin... Outperformed S&P 500 by 7.62%
5Y Performance
- Lantheus Holdin... (LNT...) 523.57%
- S&P 500 92.3%
Lantheus Holdin... Outperformed S&P 500 by 431.27%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$80.44Volume
2.98MP/E Ratio (TTM)
21.7052 Week Range
Market Cap
6.81BAvg. Volume
1.14MDividend Yield
-Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 5.07 | 6.28 | 13.57 | 18.92 | - |
EBIT per Share (TTM) | 0.3 | -1.12 | 0.53 | 7.47 | - |
Earnings per Share (EPS) (TTM) | -0.25 | -1.06 | 0.41 | 4.79 | - |
EPS Forward | - | -1.06 | 0.4 | 4.65 | - |
Super Investors
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Private Capital
% Portfolio:
6.22 Recent Activity:-3.36%
Joel Greenblatt
% Portfolio:
0.01 Recent Activity:4.84%
Ken Fisher
% Portfolio:
< 0.01 Recent Activity:0.00%
George Soros
% Portfolio:
0 Recent Activity:-
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
